BioMerieux/ FR0013280286 /
| 2024-04-18 10:13:13 AM | Chg. -0.80 | Volume | Bid10:14:28 AM | Ask10:15:01 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 100.20EUR | -0.79% | 2,104 Turnover: 86,066.83 |
100.10Bid Size: 97 | 100.20Ask Size: 89 | 11.91 bill.EUR | 0.84% | 33.20 |
Assets
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 734.5000 | 711.4000 | 807.5000 | 894.7000 | 939 | ||||||
| Intangible Assets | 492.6000 | 430.7000 | 507.3000 | 508.4000 | 430.7000 | ||||||
| Long-Term Investments | 36.9000 | 57.9000 | 71.8000 | 41.9000 | 50.6000 | ||||||
| Fixed Assets | 1,845.8000 | 1,708.5000 | 2,093.9000 | 2,343.5000 | 2,266.3000 | ||||||
| Inventories | 404.4000 | 380.3000 | 414.9000 | 494.7000 | 541.9000 | ||||||
| Accounts Receivable | 465.8000 | 460.1000 | 490 | 552.1000 | 597.9000 | ||||||
| Cash and Cash Equivalents | 178.6000 | 312.1000 | 280.1000 | 275 | 389.2000 | ||||||
| Current Assets | 1,183 | 1,279.4000 | 1,295.6000 | 1,438.5000 | 1,661.6000 | ||||||
| Total Assets | 3,028.8000 | 2,990 | 3,389.6000 | 3,781.9000 | 3,927.8000 | ||||||
Liabilities
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 175.6000 | 161.3000 | 176.9000 | 211.9000 | 207.1000 | ||||||
| Long-term debt | 365.4000 | 391.1000 | 446.8000 | 153.7000 | 352.4000 | ||||||
| Liabilities to Banks | 453.3000 | 468 | 547 | 592.3000 | 481.3000 | ||||||
| Provisions | 319.1000 | 244.6000 | 136 | 141.2000 | 105.8000 | ||||||
| Liabilities | 1,407.4000 | 1,253.3000 | 1,386.3000 | 1,527.3000 | 1,446.5000 | ||||||
| Share Capital | 12 | 12 | 12 | 12 | 12 | ||||||
| Total Equity | 1,619.1000 | 1,737.6000 | 1,929.3000 | 2,203.9000 | 2,431.1000 | ||||||
| Minority Interests | 2.2000 | -.9000 | 74 | 50.7000 | 50.2000 | ||||||
| Total liabilities equity | 3,028.8000 | 2,990 | 3,389.6000 | 3,781.9000 | 3,927.8000 | ||||||
Income Statement
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,103.2000 | 2,288.2000 | 2,421.3000 | 2,674.8000 | 3,118.2000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 282.5000 | 314.9000 | 343.6000 | 370.7000 | 595.1000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | 259.3000 | 292.1000 | 320.8000 | 347.5000 | 524.4000 | ||||||
| Income Taxes | -80.1000 | -54.5000 | -65.2000 | -77.8000 | -121.7000 | ||||||
| Minority Interests Profit | -.1000 | .6000 | 1.1000 | 3.1000 | 1.7000 | ||||||
| Net Income | 179.1000 | 238.1000 | 256.6000 | 272.8000 | 404.4000 | ||||||
Per Share
Cash Flow
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 335.6000 | 357.5000 | 386.9000 | 407.9000 | 582.8000 | ||||||
| Cash Flow from Investing Activities | -257.2000 | -180.4000 | -418.2000 | -282.2000 | -265.2000 | ||||||
| Cash Flow from Financing | -52.5000 | -68.7000 | 52.7000 | -133.9000 | -176.2000 | ||||||
| Decrease / Increase in Cash | 25.9000 | 108.4000 | 21.4000 | -8.2000 | 141.4000 | ||||||
| Employees | 9,664 | 10,321 | 11,029 | 12,000 | 13,000 | ||||||
